| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 06/09/2005 | WO2005051415A1 Method for preventing and treating diabetes using neurturin |
| 06/09/2005 | WO2005051412A2 Regulation of sperm function |
| 06/09/2005 | WO2005051408A1 Method for preventing and treating diabetes using dg119 |
| 06/09/2005 | WO2005034843A3 Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders |
| 06/09/2005 | WO2005030939A3 Method and composition for regulating expansion of stem cells |
| 06/09/2005 | WO2005030136A3 Tumor vaccine |
| 06/09/2005 | WO2005021728A3 Enriched pancreatic stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for these populations |
| 06/09/2005 | WO2005007175A3 Cadherin directed molecular and cellular localization |
| 06/09/2005 | WO2005003335A3 Rapamycin resistant t cells and therapeutic uses thereof |
| 06/09/2005 | WO2005002513A3 C1q complement inhibitors and methods of use thereof |
| 06/09/2005 | WO2005001103A3 Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses |
| 06/09/2005 | WO2005000344A3 Method for identification of tr1 lymphocytes regulators by the presence and overexpression of specific molecules and application thereof |
| 06/09/2005 | WO2004111195A3 Methods and use of zona-free therapeutic cloning |
| 06/09/2005 | WO2004106921A3 In vitro platform for screening agents inducing islet cell neogenesis |
| 06/09/2005 | WO2004104171A3 Ranbp2 as modifier of the pten/igf pathway and methods of use |
| 06/09/2005 | WO2004101743A3 Three dimensional cell cultures in a microscale fluid handling system |
| 06/09/2005 | WO2004094654A3 Transfection kinetics and structural promoters |
| 06/09/2005 | WO2004071283A3 Use of umbilical cord blood to treat individuals having a disease, disorder or condition |
| 06/09/2005 | WO2004025264A3 Rapidly degraded reporter fusion proteins |
| 06/09/2005 | WO2003062400A9 Fiber shaft modifications for efficient targeting |
| 06/09/2005 | WO2002038736A3 Methods for regulating plant gaba production |
| 06/09/2005 | US20050125862 Materials and methods for producing tomato yellow leaf curl virus resistance in plants |
| 06/09/2005 | US20050125861 DNA comprises the nucleotide sequences used for gene expression of foreign proteins in seeds; genetic engineering |
| 06/09/2005 | US20050125856 Serine O-acetyltransferase |
| 06/09/2005 | US20050125854 Rice transposon genes |
| 06/09/2005 | US20050125848 Method of isolating human neuroepithelial precursor cells from human fetal tissue |
| 06/09/2005 | US20050125846 Expression vector comprising nucleotide sequences coding transmembrant transport protein for use in diagnosis, treatment and prevention of thyroid disorders |
| 06/09/2005 | US20050124796 Mouse cytokine receptor |
| 06/09/2005 | US20050124795 DNA encoding a human subunit 5-HT3-C of the 5-HT3 serotonin receptor |
| 06/09/2005 | US20050124792 Expression vector comprising nucleotide sequences coding G-protein coupled photoreceptor proteins for use in tools in pharmaceutical design; bioreactors and heterologous protein expression |
| 06/09/2005 | US20050124789 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/09/2005 | US20050124573 Hepatitis C virus codon optimized non-structural NS3/4A fusion gene |
| 06/09/2005 | US20050124549 Method of modulating the proliferation of medullary thyroid carcinoma cells |
| 06/09/2005 | US20050124543 Heterologous polypeptide of the TNF family |
| 06/09/2005 | US20050124538 for prophylaxis, prevention, treatment or therapy of inflammatory conditions or allergic reactions in a mammal; binds bacterial lipopeptide |
| 06/09/2005 | US20050124069 Transfection reagents |
| 06/09/2005 | US20050124068 Hepatocellular carcinoma specific promoter and uses thereof |
| 06/09/2005 | US20050124067 For use in viral growth, identification, titering or manipulation; vaccine growth or manipulation; viral transduction of cells; or recombinant production, screening, or measurement of protein or protein interactions in vitro |
| 06/09/2005 | US20050124065 Using nutrient broth and porous solid support to culture and sow heterotrophic somatic plant embryo or germinant of conifer; tissue engineering and plant propagation |
| 06/09/2005 | US20050124064 Antimicrobial polypeptides from pseudoplectania nigrella |
| 06/09/2005 | US20050124063 Culture system and method for maintenance and proliferation of undifferentiated human embryonic stem cells |
| 06/09/2005 | US20050124062 Culturing mammalian tissue in nutrient broth containing laminate biofilm comprising whey protein or beta -lactoglobulin and a plasticizer; for use in tissue engineering and regenerative medicine |
| 06/09/2005 | US20050124054 Novel proteins and methods for producing the proteins |
| 06/09/2005 | US20050124016 Antibodies specific for toxic amyloid beta protein oligomers |
| 06/09/2005 | US20050124007 Human mesencephalon cell lines and methods of use therefor |
| 06/09/2005 | US20050124004 Histamine receptor h3 polynucleotides |
| 06/09/2005 | US20050124003 Using immunoaffinity selection to isolate and propagate pluripotent stem cell populations from fetal developmental tissues; cell replacement therapies |
| 06/09/2005 | US20050123963 Using genotoxically stressed checkpoint tissues as tools in detecting and monitoring efficacy of antitumor agents; drug screening |
| 06/09/2005 | US20050123961 Human G-protein coupled receptors |
| 06/09/2005 | US20050123914 Method of isolating cells and uses thereof |
| 06/09/2005 | US20050123912 Nucleoprotein for use as tool in treatment, diagnosis and prevention of infection, cell proliferative, neurological, developmental, autoimmune and inflammatory disorders |
| 06/09/2005 | US20050123910 Nucleotide sequences coding prolyl oligopeptidase (DPP10) for use in identifying modulator which prevent and treat allergies, asthma, skin and inflammatory diseases |
| 06/09/2005 | US20050123596 pH-triggered microparticles |
| 06/09/2005 | US20050123558 Modifeid polypeptide |
| 06/09/2005 | US20050123557 AntiI-protozoal vaccine |
| 06/09/2005 | US20050123551 Nucleic acids encoding polypeptides present in normal and neoplastic endometrial cells for use in diagnosis and treatment of endometrial cancer, identifying endometrial tissue; vectors, host cells; vaccines against endometrial cancer |
| 06/09/2005 | US20050123549 E.g. an antibody that binds the CA6 glycotope conjugated to a cytotoxic agent such as a maytansine; kit with instructions for treating cancer and tumors |
| 06/09/2005 | US20050123541 Anti-TNF antibodies, compositions, methods and uses |
| 06/09/2005 | US20050123534 Humanised antibodies |
| 06/09/2005 | US20050123525 Composition and method for inducing immune tolerance towards cell, tissue and/or organ transplants |
| 06/09/2005 | US20050123524 Pharmaceutical compositions and methods for treating neuronal damages and neurodegenerative diseases |
| 06/09/2005 | US20050123522 Monocyte-derived dendritic cell subsets |
| 06/09/2005 | US20050123521 Immortalization of human cells by the ectopic expression of human telomerase reverse transcriptase |
| 06/09/2005 | US20050123520 suspending tissue precursor cells in gels to form liquids, then filling the liquids into molds, implanting the mold into living host for incubation and demolding the tissues for use in surgery: tissue engineering |
| 06/09/2005 | US20050123519 nucleotide sequences, expression vectors and host cells, used for increasing the toxicity of insecticidal proteins to mosquitoes |
| 06/09/2005 | US20050123517 Transducing a neuron with a transgene from the pseudotyped retrovirus virion; gene therapy for neurodegenerative diseases; Huntington's, Parkinson's and Alzheimer's Diseases, Amyotrophic Lateral Sclerosis, ataxia, atrophy, prion disease |
| 06/09/2005 | US20050123515 retroviral vectors comprising nucleotide sequences that code envelope proteins, capable of transduction to target site |
| 06/09/2005 | US20050123514 increasing the transfer of ATP-binding cassette (ABC) transporter expressing cells with retroviral vectors, by contacting with verapamil, diltiazem, quinidine, ritonavir and lentiviruses |
| 06/09/2005 | US20050123512 Binding agents, vectors, host cells; gene therapy; nucleotide sequence with DNA insert encoding polypeptide; genetic engineering; medical diagnosis |
| 06/09/2005 | US20050123508 human granulocyte colony stimulating factor polypeptides having amino acid replacements in the sequence, used for treating hematopoietic, neurological or reproductive disorders |
| 06/09/2005 | DE10144664B4 Vacciniavirus MVA-E3L-Knock-Out-Mutanten und Verwendung hiervon Vaccinia virus MVA-E3L knock-out mutants and use thereof |
| 06/09/2005 | CA2547456A1 Means and methods for the determination of camp in vitro and in vivo |
| 06/09/2005 | CA2547320A1 Fatty acid elongase (fae) genes and their utility in increasing erucic acid and other very long-chain fatty acid proportions in seed oil |
| 06/09/2005 | CA2546763A1 Epha2 agonistic monoclonal antibodies and methods of use thereof |
| 06/09/2005 | CA2546760A1 Multipotent postnatal stem cells from human periodontal ligament and uses thereof |
| 06/09/2005 | CA2546703A1 Regulation of sperm function |
| 06/09/2005 | CA2546614A1 Dna participating in hydroxylation of macrolide compound |
| 06/09/2005 | CA2546349A1 Tangential flow filtration devices and methods for stem cell enrichment |
| 06/09/2005 | CA2545882A1 Process for recycling solid supports for cultivation of anchorage-dependent cells |
| 06/09/2005 | CA2545553A1 Methods for producing olfactory gpcrs |
| 06/09/2005 | CA2545520A1 Inhibition of stem cell differentiation, enhancement of proliferation and selective induction of apoptosis by wnt factors |
| 06/09/2005 | CA2541970A1 Gene silencing by using micro-rna molecules |
| 06/08/2005 | EP1538214A1 Enhanced production of taxanes by cell cultures of taxus species |
| 06/08/2005 | EP1538209A2 Self-assembling recombinant hpv16 papillomavirus capsid proteins |
| 06/08/2005 | EP1538202A2 Production of human alpha-galactosidase A |
| 06/08/2005 | EP1538200A1 Method of utilizing physiological activity of rare saccharide and compositions containing rare saccharide |
| 06/08/2005 | EP1538196A1 Fibrin-containing composition |
| 06/08/2005 | EP1538162A2 Compositions for altering mucus secretion |
| 06/08/2005 | EP1538161A2 32 human secreted proteins |
| 06/08/2005 | EP1538157A2 Isolation and use of SH3 binding peptides |
| 06/08/2005 | EP1537878A1 Immunopotentiating compositions |
| 06/08/2005 | EP1537417A2 Method of diagnosing colon and gastric cancers |
| 06/08/2005 | EP1537228A2 Modulators of angiogenesis |
| 06/08/2005 | EP1537219A2 Activation of tumor-reactive lymphocytes via antibodies or genes recognizing cd3 or 4-1bb |
| 06/08/2005 | EP1537218A2 Transgenic expression cassettes for expressing nucleic acids in non-reproductive flower tissues of plants |
| 06/08/2005 | EP1537216A2 Transformed plants with enhanced prenylquinone biosynthesis |
| 06/08/2005 | EP1537212A2 Human lipid phosphate phosphatases and uses thereof for treating neuronal diseases |
| 06/08/2005 | EP1537207A2 Recombinant colstridium neurotoxin fragments |
| 06/08/2005 | EP1537206A2 Infectious hepacivirus pseudo-particles containing functional e1, e2 envelope proteins |
| 06/08/2005 | EP1537204A2 Use of granzyme b as an hsp70/hsp70 peptide dependent inducer of apoptosis in tumor cells |